GEHC
NASDAQAfter HoursGE HealthCare Technologies Inc.
$82.25
$2.20 (-2.61%)
As of 10:31 AM
Open
$84.45
High
$84.50
Low
$81.74
Prev Close
$84.45
52W High
$94.80
52W Low
$57.65
Volume
3.04M
Mkt Cap
$37.57B
GE HealthCare Technologies Inc.
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue Per Share | 37.75 | 38.67 | 40.41 | 42.97 | 43.14 |
| Net Income Per Share | 30.45 | 4.94 | 4.22 | 3.45 | 4.37 |
| Operating Cash Flow Per Share | 3.71 | 3.53 | 4.65 | 4.62 | 4.28 |
| Free Cash Flow Per Share | 3.14 | 2.99 | 3.97 | 3.77 | 3.40 |
| Cash Per Share | 2.21 | 1.22 | 3.18 | 5.50 | 6.34 |
| Book Value Per Share | 32.93 | 37.16 | 21.13 | 16.07 | 18.98 |
| Tangible Book Value Per Share | 3.31 | 4.74 | -10.44 | -15.12 | -12.20 |
| Shareholders Equity Per Share | 32.39 | 36.63 | 20.61 | 15.68 | 18.52 |
| Interest Debt Per Share | 1.17 | 1.05 | 19.21 | 22.87 | 21.67 |
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Market Cap | $27.28B | $27.28B | $26.50B | $35.18B | $35.65B |
| Enterprise Value | $26.74B | $27.16B | $33.69B | $42.54B | $42.14B |
| P/E Ratio | 1.97 | 12.14 | 13.83 | 22.44 | 17.89 |
| Price-to-Sales | 1.59 | 1.55 | 1.44 | 1.80 | 1.81 |
| Price-to-Operating Cash Flow | 16.17 | 16.98 | 12.54 | 16.74 | 18.27 |
| Price-to-Free Cash Flow | 19.11 | 20.08 | 14.70 | 20.53 | 23.00 |
| P/B Ratio | 1.85 | 1.64 | 2.83 | 4.93 | 4.22 |
| Price-to-Tangible Book | 1.85 | 1.64 | 2.83 | 4.93 | 4.22 |
| EV-to-Sales | 1.56 | 1.54 | 1.84 | 2.18 | 2.14 |
| EV-to-EBITDA | 7.85 | 7.67 | 10.64 | 12.11 | 11.49 |
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Earnings Yield | 50.75% | 8.24% | 7.23% | 4.46% | 5.59% |
| Free Cash Flow Yield | 5.23% | 4.98% | 6.80% | 4.87% | 4.35% |
| Return on Equity | 94.02% | 13.49% | 20.48% | 21.98% | 23.59% |
| Return on Invested Capital | 11.58% | 11.25% | 9.56% | 6.79% | 8.29% |
| Return on Tangible Assets | 128.72% | 19.42% | 14.51% | 8.58% | 10.56% |
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Debt-to-Equity | 0.03 | 0.03 | 0.92 | 1.38 | 1.11 |
| Debt-to-Assets | 0.02 | 0.02 | 0.31 | 0.30 | 0.28 |
| Net Debt-to-EBITDA | -0.16 | -0.03 | 2.27 | 2.09 | 1.77 |
| Current Ratio | 0.84 | 0.97 | 1.09 | 1.00 | 1.00 |
| Interest Coverage | 41.21 | 69.88 | 29.33 | 4.49 | 5.20 |
| Income Quality | 0.82 | 0.71 | 1.08 | 1.30 | 0.95 |
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Days Sales Outstanding | 56.50 | 78.69 | 79.46 | 80.55 | 81.19 |
| Days Payables Outstanding | 83.80 | 95.68 | 101.04 | 92.49 | 96.19 |
| Days Inventory on Hand | 55.96 | 68.22 | 70.47 | 61.51 | 61.72 |
| Receivables Turnover | 6.46 | 4.64 | 4.59 | 4.53 | 4.50 |
| Payables Turnover | 4.36 | 3.81 | 3.61 | 3.95 | 3.79 |
| Inventory Turnover | 6.52 | 5.35 | 5.18 | 5.93 | 5.91 |
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| CapEx-to-Operating Cash Flow | 15.35% | 15.43% | 14.67% | 18.42% | 20.55% |
| CapEx-to-Revenue | 1.51% | 1.41% | 1.69% | 1.98% | 2.04% |
| CapEx-to-Depreciation | 0.41 | 0.40 | 0.49 | 0.63 | 0.69 |
| Stock-Based Comp-to-Revenue | 0.00% | 0.43% | 0.37% | 0.58% | 0.64% |
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Graham Number | 148.96 | 63.82 | 44.25 | 34.86 | 42.68 |
| Graham Net-Net | -12.00 | -11.08 | -27.38 | -40.49 | -37.93 |
| Tangible Asset Value | $1.50B | $2.16B | $-4.74B | $-6.88B | $-5.56B |
| Working Capital | $-1.08B | $-0.22B | $0.63B | $0.03B | $-0.04B |
| Invested Capital | $14.60B | $16.76B | $17.27B | $16.72B | $16.73B |